<VariationArchive VariationID="4476" VariationName="NM_031433.4(MFRP):c.498del (p.Asn167fs)" VariationType="Deletion" Accession="VCV000004476" Version="16" RecordType="classified" NumberOfSubmissions="7" NumberOfSubmitters="6" DateLastUpdated="2024-07-29" DateCreated="2018-12-15" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="19515" VariationID="4476">
      <GeneList>
        <Gene Symbol="C1QTNF5" FullName="C1q and TNF related 5" GeneID="114902" HGNC_ID="HGNC:14344" Source="calculated" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119338942" stop="119346705" display_start="119338942" display_stop="119346705" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="119209651" stop="119217382" display_start="119209651" display_stop="119217382" Strand="-" />
          </Location>
          <OMIM>608752</OMIM>
        </Gene>
        <Gene Symbol="MFRP" FullName="membrane frizzled-related protein" GeneID="83552" HGNC_ID="HGNC:18121" Source="submitted" RelationshipType="within multiple genes by overlap">
          <Location>
            <CytogeneticLocation>11q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119338942" stop="119346705" display_start="119338942" display_stop="119346705" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="119209651" stop="119217382" display_start="119209651" display_stop="119217382" Strand="-" />
          </Location>
          <OMIM>606227</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_031433.4(MFRP):c.498del (p.Asn167fs)</Name>
      <CanonicalSPDI>NC_000011.10:119345562:GGGGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="119345563" stop="119345563" display_start="119345563" display_stop="119345563" variantLength="1" positionVCF="119345562" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="119216273" stop="119216273" display_start="119216273" display_stop="119216273" variantLength="1" positionVCF="119216272" referenceAlleleVCF="TG" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>N167fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031433.3" sequenceAccession="NM_031433" sequenceVersion="3" change="c.498delC">
            <Expression>NM_031433.3:c.498delC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.119345569del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.119345569del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.119216279del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.119216279del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012235.1" sequenceAccession="NG_012235" sequenceVersion="1" change="g.6111del">
            <Expression>NG_012235.1:g.6111del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015645.5" sequenceAccession="NM_015645" sequenceVersion="5" change="c.-2139del">
            <Expression>NM_015645.5:c.-2139del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001623" Type="5 prime UTR variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_031433.4" sequenceAccession="NM_031433" sequenceVersion="4" change="c.498del" MANESelect="true">
            <Expression>NM_031433.4:c.498del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_113621.1" sequenceAccession="NP_113621" sequenceVersion="1" change="p.Asn167fs">
            <Expression>NP_113621.1:p.Asn167fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA017228" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="606227.0003" DB="OMIM" />
        <XRef Type="rs" ID="587776596" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_031433.4(MFRP):c.498del (p.Asn167fs) AND Nanophthalmos 2" Accession="RCV000004733" Version="16">
        <ClassifiedConditionList TraitSetID="1236">
          <ClassifiedCondition DB="MedGen" ID="C1836006">Nanophthalmos 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-05-04" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031433.4(MFRP):c.498del (p.Asn167fs) AND Isolated microphthalmia 5" Accession="RCV000161911" Version="20">
        <ClassifiedConditionList TraitSetID="1237">
          <ClassifiedCondition DB="MedGen" ID="C1970236">Isolated microphthalmia 5</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-11-13" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031433.4(MFRP):c.498del (p.Asn167fs) AND not provided" Accession="RCV001579996" Version="14">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_031433.4(MFRP):c.498del (p.Asn167fs) AND MFRP-related disorder" Accession="RCV004532288" Version="1">
        <ClassifiedConditionList TraitSetID="47292">
          <ClassifiedCondition>MFRP-related disorder</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-04-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-11-13" NumberOfSubmissions="7" NumberOfSubmitters="6" DateCreated="2018-12-15" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12140190</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15976030</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">17167404</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">18554571</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19753314</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">20361016</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22605927</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23112574</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23143909</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1236" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3437" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">NANOPHTHALMIA 2</ElementValue>
                <XRef Type="MIM" ID="609549" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">NANOPHTHALMOS, AUTOSOMAL RECESSIVE</ElementValue>
                <XRef Type="MIM" ID="609549" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Nanophthalmos 2</ElementValue>
                <XRef ID="Nanophthalmos+2/8969" DB="Genetic Alliance" />
                <XRef ID="MONDO:0012299" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">NNO2</ElementValue>
                <XRef Type="MIM" ID="609549" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="18626" />
                <XRef ID="18626" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="35612" DB="Orphanet" />
              <XRef ID="C1836006" DB="MedGen" />
              <XRef ID="MONDO:0012299" DB="MONDO" />
              <XRef Type="MIM" ID="609549" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="47292" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="41722" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">MFRP-related disorders</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">MFRP-related disorder</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MFRP-related condition</ElementValue>
              </Name>
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1237" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3194" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Isolated microphthalmia 5</ElementValue>
                <XRef ID="MONDO:0012605" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Posterior Microphthalmia with Retinitis Pigmentosa, Foveoschisis, and Optic Disc Drusen</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MCOP5</ElementValue>
                <XRef Type="MIM" ID="611040" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17205" />
                <XRef ID="17205" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="251279" DB="Orphanet" />
              <XRef ID="C1970236" DB="MedGen" />
              <XRef ID="MONDO:0012605" DB="MONDO" />
              <XRef Type="MIM" ID="611040" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="381786" SubmissionDate="2016-08-11" DateLastUpdated="2018-12-15" DateCreated="2015-03-03">
        <ClinVarSubmissionID localKey="606227.0003_MICROPHTHALMIA, ISOLATED 5" title="MFRP, 1-BP DEL, 498C_MICROPHTHALMIA, ISOLATED 5" />
        <ClinVarAccession Accession="SCV000211941" DateUpdated="2018-12-15" DateCreated="2015-03-03" Type="SCV" Version="4" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to included disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Since this 1-bp deletion occurs in a stretch of 7 C nucleotides, the most 3-prime position is assigned the site of the mutation; hence this mutation is referred to as c.498delC rather than as c.492delC (1-BP DEL, 492C) as notated by Sundin et al. (2005).</Attribute>
              <Citation>
                <ID Source="PubMed">15976030</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Nanophthalmos 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sisters with nanophthalmos-2 (NNO2; 609549), Sundin et al. (2005) identified compound heterozygosity for 2 mutations in exon 5 of the MFRP gene: a 1-bp deletion (492delC) and an ile182-to-thr (I182T) substitution (606227.0004). The deletion was predicted to truncate the protein in one of the cubilin domains and remove the cysteine-rich domain.</Attribute>
              <Citation>
                <ID Source="PubMed">15976030</ID>
              </Citation>
              <XRef DB="OMIM" ID="609549" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Isolated Microphthalmia 5</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 3 brothers from a consanguineous Spanish family with posterior microphthalmia, retinitis pigmentosa (RP), foveoschisis, and optic disc drusen (MCOP5; 611040), Crespi et al. (2008) identified homozygosity for a 1-bp deletion in exon 5 of the MFRP gene, which they designated 498delC, causing a frameshift predicted to result in a premature termination codon 25 codons downstream (Pro166fsTer190). The authors noted that this truncated protein would lack almost all functional domains, including the 2 cubilin-related, 2 low-density lipoprotein receptor-related, and C-terminal cysteine-rich frizzled-related domains. The deletion was present in heterozygosity in an unaffected sister.</Attribute>
              <Citation>
                <ID Source="PubMed">18554571</ID>
              </Citation>
              <XRef DB="OMIM" ID="611040" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Mexican sister and brother with posterior microphthalmia, RP, foveoschisis, and optic disc drusen, Zenteno et al. (2009) identified compound heterozygosity for the 498delC deletion and a C-to-A transversion in exon 5 in the MFRP gene, resulting in a tyr317-to-ter (Y317X; 606227.0006) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">19753314</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 42-year-old man who had high hypermetropia, retinal dysfunction with night blindness from early childhood, and optic disc drusen, Mukhopadhyay et al. (2010) identified homozygosity for the 498delC mutation in MFRP. In a 34-year-old woman with high hypermetropia and retinal dysfunction, in whom ERGs showed a rod-cone pattern of dysfunction with severe rod system involvement, Mukhopadhyay et al. (2010) identified compound heterozygosity for 498delC and a 4-bp deletion (c.1622_1625delTCTG; 606227.0007) in the MFRP gene. Both patients had foveal cystic spaces observed on optical coherence tomography.</Attribute>
              <Citation>
                <ID Source="PubMed">20361016</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 3 sibs from a consanguineous southern Indian family with extreme hyperopia and RP mapping to chromosome 11, Kannabiran et al. (2012) identified homozygosity for the 498delC mutation in the MFRP gene. Their unaffected parents were heterozygous for the mutation, which was not found in 100 controls. The authors noted that the affected individuals exhibited clinically atypical RP, with the 2 younger sibs having high hyperopia of +11 and +13 diopters, and the oldest sib having slightly more pigments and macular involvement. Kannabiran et al. (2012) noted that the C residue at position 498 is part of a stretch of 7 C residues, starting at c.492, that appears to represent a mutation hotspot for the MFRP gene.</Attribute>
              <Citation>
                <ID Source="PubMed">22605927</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ayala-Ramirez et al. (2006) reported an insertional frameshift mutation at this position (606227.0005).</Attribute>
              <Citation>
                <ID Source="PubMed">17167404</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <Name>MFRP, 1-BP DEL, 498C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 498C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606227.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="included">MICROPHTHALMIA, ISOLATED 5</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="24909" SubmissionDate="2016-08-11" DateLastUpdated="2018-12-15" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="606227.0003_NANOPHTHALMOS 2" title="MFRP, 1-BP DEL, 498C_NANOPHTHALMOS 2" />
        <ClinVarAccession Accession="SCV000024909" DateUpdated="2018-12-15" DateCreated="2013-04-04" Type="SCV" Version="6" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2012-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Since this 1-bp deletion occurs in a stretch of 7 C nucleotides, the most 3-prime position is assigned the site of the mutation; hence this mutation is referred to as c.498delC rather than as c.492delC (1-BP DEL, 492C) as notated by Sundin et al. (2005).</Attribute>
              <Citation>
                <ID Source="PubMed">15976030</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Nanophthalmos 2</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 2 sisters with nanophthalmos-2 (NNO2; 609549), Sundin et al. (2005) identified compound heterozygosity for 2 mutations in exon 5 of the MFRP gene: a 1-bp deletion (492delC) and an ile182-to-thr (I182T) substitution (606227.0004). The deletion was predicted to truncate the protein in one of the cubilin domains and remove the cysteine-rich domain.</Attribute>
              <Citation>
                <ID Source="PubMed">15976030</ID>
              </Citation>
              <XRef DB="OMIM" ID="609549" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Isolated Microphthalmia 5</Attribute>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 3 brothers from a consanguineous Spanish family with posterior microphthalmia, retinitis pigmentosa (RP), foveoschisis, and optic disc drusen (MCOP5; 611040), Crespi et al. (2008) identified homozygosity for a 1-bp deletion in exon 5 of the MFRP gene, which they designated 498delC, causing a frameshift predicted to result in a premature termination codon 25 codons downstream (Pro166fsTer190). The authors noted that this truncated protein would lack almost all functional domains, including the 2 cubilin-related, 2 low-density lipoprotein receptor-related, and C-terminal cysteine-rich frizzled-related domains. The deletion was present in heterozygosity in an unaffected sister.</Attribute>
              <Citation>
                <ID Source="PubMed">18554571</ID>
              </Citation>
              <XRef DB="OMIM" ID="611040" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a Mexican sister and brother with posterior microphthalmia, RP, foveoschisis, and optic disc drusen, Zenteno et al. (2009) identified compound heterozygosity for the 498delC deletion and a C-to-A transversion in exon 5 in the MFRP gene, resulting in a tyr317-to-ter (Y317X; 606227.0006) substitution.</Attribute>
              <Citation>
                <ID Source="PubMed">19753314</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In a 42-year-old man who had high hypermetropia, retinal dysfunction with night blindness from early childhood, and optic disc drusen, Mukhopadhyay et al. (2010) identified homozygosity for the 498delC mutation in MFRP. In a 34-year-old woman with high hypermetropia and retinal dysfunction, in whom ERGs showed a rod-cone pattern of dysfunction with severe rod system involvement, Mukhopadhyay et al. (2010) identified compound heterozygosity for 498delC and a 4-bp deletion (c.1622_1625delTCTG; 606227.0007) in the MFRP gene. Both patients had foveal cystic spaces observed on optical coherence tomography.</Attribute>
              <Citation>
                <ID Source="PubMed">20361016</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">In 3 sibs from a consanguineous southern Indian family with extreme hyperopia and RP mapping to chromosome 11, Kannabiran et al. (2012) identified homozygosity for the 498delC mutation in the MFRP gene. Their unaffected parents were heterozygous for the mutation, which was not found in 100 controls. The authors noted that the affected individuals exhibited clinically atypical RP, with the 2 younger sibs having high hyperopia of +11 and +13 diopters, and the oldest sib having slightly more pigments and macular involvement. Kannabiran et al. (2012) noted that the C residue at position 498 is part of a stretch of 7 C residues, starting at c.492, that appears to represent a mutation hotspot for the MFRP gene.</Attribute>
              <Citation>
                <ID Source="PubMed">22605927</ID>
              </Citation>
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">Ayala-Ramirez et al. (2006) reported an insertional frameshift mutation at this position (606227.0005).</Attribute>
              <Citation>
                <ID Source="PubMed">17167404</ID>
              </Citation>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <Name>MFRP, 1-BP DEL, 498C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 498C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="606227.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">NANOPHTHALMOS 2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3549220" SubmissionDate="2021-08-24" DateLastUpdated="2021-08-26" DateCreated="2021-08-26">
        <ClinVarSubmissionID localKey=":Chr.11_119216272_119216273_TG_T|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001809303" DateUpdated="2021-08-26" DateCreated="2021-08-26" Type="SCV" Version="1" SubmitterName="Genome Diagnostics Laboratory, Amsterdam University Medical Center" OrgID="506453" OrganizationCategory="laboratory" OrgAbbreviation="VUMC GD" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="T" referenceAllele="TG" start="119216272" stop="119216273" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10240015</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3836440" SubmissionDate="2021-09-30" DateLastUpdated="2021-10-02" DateCreated="2021-10-02">
        <ClinVarSubmissionID localKey=":Chr.11_119216272_119216273_TG_T|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001959935" DateUpdated="2021-10-02" DateCreated="2021-10-02" Type="SCV" Version="1" SubmitterName="Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+" OrgID="505925" OrganizationCategory="laboratory" OrgAbbreviation="Radboudumc_MUMC+" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="506382" SubmitterName="Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen" Type="behalf" OrganizationCategory="laboratory" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <SequenceLocation Assembly="GRCh37" Chr="11" alternateAllele="T" referenceAllele="TG" start="119216272" stop="119216273" variantLength="2" />
          </Location>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <StudyName>VKGL Data-share Consensus</StudyName>
        <SubmissionNameList>
          <SubmissionName>SUB10449206</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7697883" SubmissionDate="2023-10-19" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="2393927|MFRP-related condition" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004116656" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="PreventionGenetics, part of Exact Sciences" OrgID="239772" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-04-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>The MFRP c.498delC variant is predicted to result in a frameshift and premature protein termination (p.Pro166Profs*26). This variant has been reported in the homozygous and compound heterozygous states in individuals with nanophthalmos or retinal dystrophy (reported as 492delC in Sundin et al. 2005. PubMed ID: 15976030; Kannabiran et al. 2012. PubMed ID: 22605927; Guo et al. 2019. PubMed ID: 31266062; Prasov et al. 2020. PubMed ID: 33203948). This variant is reported in 0.042% of alleles in individuals of Latino descent in gnomAD (http://gnomad.broadinstitute.org/variant/11-119216272-TG-T). Frameshift variants in MFRP are expected to be pathogenic, and this variant has been classified as pathogenic by multiple independent submitters to the ClinVar database (https://www.ncbi.nlm.nih.gov/clinvar/variation/4476). Given the evidence, we interpret this variant as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_031433.3:c.498delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MFRP-related condition</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13915440</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2746301" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2020-07-16">
        <ClinVarSubmissionID localKey="1909223|MedGen:C1970236" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001411243" DateUpdated="2024-02-20" DateCreated="2020-07-16" Type="SCV" Version="5" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12140190</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15976030</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20361016</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19753314</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23112574</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23143909</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Asn167Thrfs*25) in the MFRP gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MFRP are known to be pathogenic (PMID: 12140190, 15976030, 20361016). This variant is present in population databases (rs587776596, gnomAD 0.04%). This premature translational stop signal has been observed in individuals with posterior microphthalmos/nanophthalmos and retinal dystrophy in a family, and has been observed in several affected individuals (PMID: 19753314, 23112574, 23143909). It has also been observed to segregate with disease in related individuals. This variant is also known as c.492delC, p.P166fs*26, and p.P166fs*190. ClinVar contains an entry for this variant (Variation ID: 4476). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.119216273del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1970236" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200279</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4933399" SubmissionDate="2022-05-21" DateLastUpdated="2022-05-24" DateCreated="2022-05-24">
        <ClinVarSubmissionID localKey="NC_000011.10:g.119345563_119345563delG|OMIM:609549" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002517614" DateUpdated="2022-05-24" DateCreated="2022-05-24" Type="SCV" Version="1" SubmitterName="Mendelics" OrgID="500035" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-05-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Mendelics Assertion Criteria 2019</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fxi2k7be/mendelics_assertion_criteria_2019.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="MFRP" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.10:g.119345563_119345563delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="609549" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>MENDELICS_CLINVAR_033</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3836440" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="2746301" TraitType="Disease" MappingType="XRef" MappingValue="C1970236" MappingRef="MedGen">
        <MedGen CUI="C1970236" Name="Isolated microphthalmia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="24909" TraitType="Disease" MappingType="Name" MappingValue="NANOPHTHALMOS 2" MappingRef="Preferred">
        <MedGen CUI="C1836006" Name="Nanophthalmos 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7697883" TraitType="Disease" MappingType="Name" MappingValue="MFRP-related condition" MappingRef="Preferred">
        <MedGen CUI="None" Name="MFRP-related disorder" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="381786" TraitType="Disease" MappingType="Name" MappingValue="MICROPHTHALMIA, ISOLATED 5" MappingRef="Alternate">
        <MedGen CUI="C1970236" Name="Isolated microphthalmia 5" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4933399" TraitType="Disease" MappingType="XRef" MappingValue="609549" MappingRef="OMIM">
        <MedGen CUI="C1836006" Name="Nanophthalmos 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3549220" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
    <DeletedSCVList>
      <SCV>
        <Accession Version="1" DateDeleted="2023-03-03">SCV002024348</Accession>
        <Description>not specified</Description>
      </SCV>
    </DeletedSCVList>
  </ClassifiedRecord>
</VariationArchive>

